biote Corp. (BTMD)
1.07
-0.02
(-1.83%)
USD |
NASDAQ |
Oct 23, 16:00
1.06
-0.01
(-0.93%)
After-Hours: 20:00
biote Enterprise Value : 154.67M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 154.67M |
| October 22, 2026 | 155.22M |
| October 21, 2026 | 153.56M |
| October 20, 2026 | 154.67M |
| October 19, 2026 | 154.94M |
| October 16, 2026 | 155.08M |
| October 15, 2026 | 155.77M |
| October 14, 2026 | 156.33M |
| October 13, 2026 | 153.84M |
| October 12, 2026 | 156.60M |
| October 09, 2026 | 156.88M |
| October 08, 2026 | 157.43M |
| October 07, 2026 | 155.77M |
| October 06, 2026 | 156.60M |
| October 05, 2026 | 156.05M |
| October 02, 2026 | 156.88M |
| October 01, 2026 | 157.16M |
| September 30, 2026 | 158.54M |
| September 29, 2026 | 159.37M |
| September 28, 2026 | 159.09M |
| September 25, 2026 | 158.82M |
| September 24, 2026 | 159.09M |
| September 23, 2026 | 161.03M |
| September 22, 2026 | 161.58M |
| September 21, 2026 | 161.72M |
| Date | Value |
|---|---|
| September 18, 2026 | 162.69M |
| September 17, 2026 | 162.41M |
| September 16, 2026 | 162.14M |
| September 15, 2026 | 163.52M |
| September 14, 2026 | 163.80M |
| September 11, 2026 | 161.86M |
| September 10, 2026 | 161.31M |
| September 09, 2026 | 165.18M |
| September 08, 2026 | 166.84M |
| September 04, 2026 | 167.81M |
| September 03, 2026 | 167.95M |
| September 02, 2026 | 171.82M |
| September 01, 2026 | 171.26M |
| August 31, 2026 | 170.44M |
| August 28, 2026 | 168.50M |
| August 27, 2026 | 170.16M |
| August 26, 2026 | 167.95M |
| August 25, 2026 | 168.78M |
| August 24, 2026 | 168.50M |
| August 21, 2026 | 169.61M |
| August 20, 2026 | 166.01M |
| August 19, 2026 | 162.69M |
| August 18, 2026 | 161.03M |
| August 17, 2026 | 162.97M |
| August 14, 2026 | 165.73M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cannabis Strategic Ventures, Inc. | 2.772M |
| Rafael Holdings, Inc. | 43.64M |
| Concentra Group Holdings Parent, Inc. | 7.020B |
| Elite Health Systems, Inc. | 22.39M |
| U.S. Stem Cell, Inc. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.428M |
| Revenue (Quarterly) | 44.23M |
| Total Expenses (Quarterly) | 50.80M |
| EPS Diluted (Quarterly) | -0.2293 |
| Gross Profit Margin (Quarterly) | 63.69% |
| Profit Margin (Quarterly) | -16.79% |
| Earnings Yield | 11.25% |
| Operating Earnings Yield | 62.48% |
| Normalized Earnings Yield | 18.64 |